Menu
Menu
Le invitamos a participar en este exclusivo encuentro que reunirá a expertos y líderes clínicos para explorar los avances más recientes en medicina de precisión y genómica aplicada.
El evento contará con la participación del Presidente de SOPHiA GENETICS, quien compartirá la visión global de la compañía, así como con especialistas que abordarán el impacto de NGS en hemato-oncología y las tendencias futuras del área.
Asimismo, el evento destacará experiencias reales de clientes que compartirán su práctica clínica utilizando la plataforma SOPHiA DDM™, ofreciendo una perspectiva concreta sobre su impacto en el diagnóstico y la toma de decisiones.
A continuación, encontrará la agenda preliminar del evento.
What: SOPHiA GENETICS Exclusive Networking event
Where: Savoy Hotel
Date: 21 de abril
Time: 19:00 - 22:00
19:00 – 19:30
Leading Innovation to Impact: SOPHiA GENETICS’ Global Vision
Ross Muken, President, SOPHiA GENETICS
19:30 – 20:00
Panel NGS para LLC: implementación y validación analítica.
Mauro García-Montenegro
Jefe Anatomia Patologia, Argenetics
20:00 - 20:30
Paneles de genes mediante NGS: Transformando el estudio de las neoplasias mieloides
Andrea Bender, Especialista en Bioquímica Clínica Laboratorio de Especialidades Bioquimicas (LEB)
20:30 – 21:00
What’s Next in Hemato-Oncology Genomics
Bruno Piovezan, Subject Matter Expert LATAM, SOPHiA GENETICS
21:00 – 22:00
Cocktails & Networking
Discover how SOPHiA DDM™ enables accurate analysis across multiple disease areas – from oncology to inherited disorders
Discuss the future of research and healthcare institutions to harness NGS data for quick, robust, and actionable insights, guiding best decisions.
Connect with your peers and enjoy a networking environment with your peers and users of SOPHiA DDM™ Platform
El GENOMiCS INSIGHTS Day Bogotá se llevará a cabo el próximo 23 de abril, en el Hotel W Bogotá.
Este encuentro reunirá a expertos, líderes clínicos y profesionales del área de la genómica para explorar los avances más recientes en medicina de precisión y el impacto creciente de las tecnologías genómicas en la práctica clínica.
Durante la jornada abordaremos temas clave como la visión global de innovación de SOPHiA GENETICS, las nuevas posibilidades clínicas de la biopsia líquida, experiencias reales de implementación en la práctica clínica con la plataforma SOPHiA DDM™, y nuevas oportunidades para ampliar el análisis genómico mediante exomas optimizados.
Este espacio también busca fomentar el intercambio de experiencias y la conversación entre profesionales del sector, promoviendo el avance de la medicina genómica en la región.
A continuación, encontrará la agenda preliminar del evento.
16:00 – 16:30
De la innovación al impacto: la visión global de SOPHiA GENETICS.
Ross Muken, President, SOPHiA GENETICS
16:30 – 17:00
Expandiendo las posibilidades clínicas con las soluciones de biopsia líquida de SOPHiA GENETICS.
Luna Rodriguez, Subject Matter Expert LATAM, SOPHiA GENETICS
17:00 - 17:30
Biopsia líquida en la práctica clínica: experiencia real con la plataforma SOPHiA DDM™.
July Katherine Rodriguez Ariza, Directora científica, FICMAC
17:30 – 18:00
Exomas optimizados: una nueva oportunidad para expandir el análisis genómico.
Gabriela Acosta, Sales Executive, LATAM SOPHiA GENETICS
Discover how SOPHiA DDM™ enables accurate analysis across multiple disease areas – from oncology to inherited disorders
Discuss the future of research and healthcare institutions to harness NGS data for quick, robust, and actionable insights, guiding best decisions.
Connect with your peers and enjoy a networking environment with your peers and users of SOPHiA DDM™ Platform
Join SOPHiA GENETICS at the European Human Genetics Conference (ESHG) 2026 in Gothenburg, Sweden! Our team of experts will be at Booth #214 to engage with partners and peers across the genomics community.
Stay tuned for information and session updates!
SOPHiA GENETICS is thrilled to return for ACMG 2026! Visit us at booth #1007 to learn more about our SOPHiA DDM™ and Alamut™ Visual Plus platforms for rare and inherited diseases.
Discover more about our newly launched extended pharmacogenomics (PGx) application, which covers HLA and mitochrondrial regions, with dedicated analytical modules that call variants from SNVs and CNvs to star alleles and CYP2D6/CVP2D7 gene conversion.
Learn more about SOPHiA DDM™ for whole genome sequencing and how our enhanced exome solutions detect challenging variants relevant for carrier screening, hereditary cancer, and PGx in one comprehensive application.
Exhibit Theater 1
Thursday March 12
12:30pm-1:00pm
Future-Ready Genomics: Real World Implementation and Validation from Hereditary Cancer to WGS
Dr. Francisco Perez Blanco, PhD, Chief of Molecular Diagnostics and Biometrics Laboratory, Clinical Alemana de Santiago
Sevana Yaghoubian, MSc - Senior Director of Product Management, SOPHiA GENETICS.
Join this talk to hear real-world clinical experience, implementation, and validation insights, and performance data from SOPHiA DDM™ germline NGS applications, covering hereditary cancer, enhanced exomes, whole-genome sequencing, and pharmacogenomics.
San Sebastián, Donostia, Basque Country | Real Sociedad Arena
Join us in the vibrant coastal city of San Sebastián for the SOPHiA GENETICS Innovation Summit 2026.
From June 24-25, 2026, our global community of healthcare leaders, researchers, clinicians, and BioPharma innovators will come together for another year to explore the breakthroughs transforming oncology and rare disease care.
Join us at the spectacular Real Sociedad Arena for a memorable community experience! This iconic venue, home to one of Spain’s most celebrated football clubs, will provide a dynamic and inspiring setting for our community to connect, learn, and innovate.
Building on the success of our inaugural event in Rolle, Switzerland in 2025, this next chapter will spark thought-provoking discussions, unveil forward-thinking technologies, and offer unparalleled networking opportunities - in a city renowned for its innovation and culture!
Don’t miss this unique opportunity to engage with peers, deepen collaborations, and stay at the forefront of precision medicine, in one of Spain’s most iconic locations.
We are glad to return to Swiss Biotech Day 2026, where you will have the chance to meet our BioPharma and Medical teams for two days of exciting networking, innovation, and insights sharing on the potential of AI-driven solutions to transform precision medicine.
SOPHiA GENETICS is thrilled to be back at ASCO 2026! Meet our experts at booth #32131 to hear about our biopharma solutions. Learn how we are leveraging our unique AI expertise, to provide an unparalleled offering, unlocking insights from complex data types, driving faster discovery of new stratifying biomarkers, in addition to aiding in the commercialization of precision medicines
We are thrilled to be the inaugural World Companion Diagnostics & Liquid Biopsy Summit Japan. Join us and meet our BioPharma team to learn how we help BioPharma companies address challenges throughout the drug development continuum, enhancing efficiency and precision to accelerate the development of better and more effective precision therapeutics.
SOPHiA GENETICS is thrilled to be back at AACR 2026! Visit us at booth #4248 to learn how we advance data-driven medicine, with our cloud-based SOPHiA DDM™ Platform. Discover how it empowers health data interpretation with advanced analytics modules, simplified reporting, and a global community of healthcare institutions. By harnessing the power of AI and multimodal data-driven analytics, we enable you to advance and streamline global access to precision therapies.
If you are around, don’t miss our Poster presentation on Wednesday, April 22nd, from 9.00 am to 12.00 pm.
Poster #7820: CHIP detection in solid tumors differs between liquid biopsy testing approaches.
Florian Klemm, Technical Product Management Expert, SOPHiA GENETICS
We are thrilled to be back at 16th World Clinical Biomarkers & Companion Diagnostics Summit Europe. Join us and meet our BioPharma team to learn how we help BioPharma companies address challenges throughout the drug development continuum, enhancing efficiency and precision to accelerate the development of better and more effective precision therapeutics.
The SOPHiA GENETICS team is looking forward to seeing you join our Pre-Conference Workshop Day and Plenary Talk.
Pre-Conference Workshop Day on Monday, March 30th, from 2.30 to 4.30 pm.
“Pioneering Precision Medicine: A Hybrid Future for CDx”
In this workshop, we will explore how a groundbreaking industry collaboration is rethinking current CDx approaches through a hybrid model designed for rapid scalability and access in precision medicine.
This is an invitation-only workshop session. If you are interested in attending, please fill out our Engager Form
Plenary talk on Tuesday, March 31st, from 12.00 to 12.30 pm.
“Establishing a Scalable Liquid Biopsy Strategy: Foundations of a Global CDx Ecosystem”
Florian Klemm, Technical Product Management Expert, SOPHiA GENETICS
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.